Science & Innovation

Glaucoma genetic test predicts risk and disease progression

A glaucoma genetic test predicts risk and disease progression. Researchers explain its promise for earlier screening and its limits across ancestry groups.

A layered paper eye with a branching retinal pattern.

AI-generated image

A glaucoma genetic test helped predict who might develop the disease and whose condition might worsen. Flinders University and QIMR Berghofer led the Australian research, published in Ophthalmology.

The aim is to help doctors decide who may need earlier screening or closer monitoring. Flinders eye researcher Jamie Craig said many patients only learn they have glaucoma after lasting damage has occurred.

What the glaucoma genetic test measures

The peer-reviewed study in Ophthalmology looked at links between genes and open-angle glaucoma. It tested how well a score could predict risk. The team used genetic study data from more than 6 million people. It then checked the score in other groups.

A polygenic risk score combines many small DNA differences into an estimate of disease risk. The National Human Genome Research Institute says such scores use genes alone. They leave out other factors, such as a person’s habits or surroundings. A high score does not mean a person will get the disease.

The study authors found a gap in an Australian group. Those in the highest-scoring 10% developed glaucoma about 25 years earlier, on average, than those in the lowest-scoring 10%. Higher scores also predicted a greater need to start or step up treatment. These links do not prove that using the test prevents sight loss.

Why eye exams still matter

Glaucoma damages a nerve at the back of the eye called the optic nerve. According to the National Eye Institute, early symptoms are often absent. Sight loss can begin at the edges of vision and develop so slowly that people do not notice.

A comprehensive eye exam uses drops to widen the pupil so a doctor can check for damage. It also tests side vision. Treatments include eye drops, lasers and surgery. They cannot restore vision already lost, but can help stop damage from getting worse.

Limits and next steps

The study authors said the glaucoma genetic test worked best in people of European ancestry. They warned that weaker results in other groups could widen gaps in care. Most data came from Australia, the United Kingdom and the United States.

The authors said doctors can access the score through Seonix Bio. However, they have yet to pin down which scores should trigger screening. They called for trials that track people over time to help set those cutoffs.

Sources: Ophthalmology, Flinders University, National Eye Institute, National Human Genome Research Institute